日本新薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2014/03/06 | 1,920 | 1,973 | 1,916 | 1,965 | +40 | +2.1% | 248,000 |
2014/03/05 | 1,950 | 1,965 | 1,923 | 1,925 | +6 | +0.3% | 157,000 |
2014/03/04 | 1,904 | 1,937 | 1,888 | 1,919 | -3 | -0.2% | 205,000 |
2014/03/03 | 1,963 | 1,963 | 1,916 | 1,922 | -27 | -1.4% | 151,000 |
2014/02/28 | 1,904 | 1,957 | 1,884 | 1,949 | +55 | +2.9% | 324,000 |
2014/02/27 | 1,919 | 1,922 | 1,880 | 1,894 | -23 | -1.2% | 262,000 |
2014/02/26 | 1,933 | 1,950 | 1,912 | 1,917 | -36 | -1.8% | 271,000 |
2014/02/25 | 1,961 | 1,962 | 1,935 | 1,953 | -3 | -0.2% | 317,000 |
2014/02/24 | 1,961 | 1,987 | 1,932 | 1,956 | -26 | -1.3% | 132,000 |
2014/02/21 | 1,962 | 1,990 | 1,956 | 1,982 | +25 | +1.3% | 117,000 |
2014/02/20 | 1,953 | 1,984 | 1,940 | 1,957 | +3 | +0.2% | 138,000 |
2014/02/19 | 1,990 | 2,000 | 1,954 | 1,954 | -37 | -1.9% | 201,000 |
2014/02/18 | 1,964 | 2,003 | 1,943 | 1,991 | +43 | +2.2% | 162,000 |
2014/02/17 | 1,912 | 1,954 | 1,894 | 1,948 | +41 | +2.1% | 133,000 |
2014/02/14 | 1,925 | 1,965 | 1,886 | 1,907 | -12 | -0.6% | 250,000 |
2014/02/13 | 1,941 | 1,951 | 1,914 | 1,919 | -36 | -1.8% | 237,000 |
2014/02/12 | 1,971 | 1,998 | 1,945 | 1,955 | -19 | -1% | 255,000 |
2014/02/10 | 1,962 | 1,984 | 1,955 | 1,974 | +38 | +2% | 177,000 |
2014/02/07 | 1,960 | 1,960 | 1,887 | 1,936 | +101 | +5.5% | 237,000 |
2014/02/06 | 1,893 | 1,913 | 1,831 | 1,835 | -64 | -3.4% | 211,000 |
2014/02/05 | 1,885 | 1,910 | 1,859 | 1,899 | +26 | +1.4% | 187,000 |
2014/02/04 | 1,924 | 1,924 | 1,871 | 1,873 | -94 | -4.8% | 258,000 |
2014/02/03 | 2,000 | 2,000 | 1,949 | 1,967 | -41 | -2% | 237,000 |
2014/01/31 | 2,020 | 2,047 | 1,991 | 2,008 | +2 | +0.1% | 156,000 |
2014/01/30 | 2,056 | 2,056 | 1,990 | 2,006 | -57 | -2.8% | 205,000 |
2014/01/29 | 2,012 | 2,063 | 2,012 | 2,063 | +61 | +3% | 117,000 |
2014/01/28 | 2,001 | 2,031 | 1,990 | 2,002 | +2 | +0.1% | 191,000 |
2014/01/27 | 1,990 | 2,028 | 1,968 | 2,000 | -35 | -1.7% | 215,000 |
2014/01/24 | 2,048 | 2,055 | 2,023 | 2,035 | -25 | -1.2% | 261,000 |
2014/01/23 | 2,068 | 2,082 | 2,050 | 2,060 | -3 | -0.1% | 260,000 |
2014/01/22 | 2,089 | 2,093 | 2,033 | 2,063 | -25 | -1.2% | 214,000 |
2014/01/21 | 2,086 | 2,100 | 2,056 | 2,088 | +27 | +1.3% | 233,000 |
2014/01/20 | 2,088 | 2,095 | 2,049 | 2,061 | -17 | -0.8% | 194,000 |
2014/01/17 | 2,077 | 2,089 | 2,062 | 2,078 | +5 | +0.2% | 117,000 |
2014/01/16 | 2,071 | 2,089 | 2,059 | 2,073 | +8 | +0.4% | 111,000 |
2014/01/15 | 2,069 | 2,069 | 2,032 | 2,065 | +33 | +1.6% | 181,000 |
2014/01/14 | 2,065 | 2,073 | 2,012 | 2,032 | -33 | -1.6% | 344,000 |
2014/01/10 | 1,964 | 2,068 | 1,962 | 2,065 | +113 | +5.8% | 523,000 |
2014/01/09 | 2,000 | 2,009 | 1,948 | 1,952 | +8 | +0.4% | 426,000 |
2014/01/08 | 1,971 | 1,971 | 1,906 | 1,944 | -77 | -3.8% | 660,000 |
2014/01/07 | 2,047 | 2,056 | 2,010 | 2,021 | -11 | -0.5% | 117,000 |
2014/01/06 | 2,050 | 2,072 | 1,997 | 2,032 | -17 | -0.8% | 163,000 |
2013/12/30 | 2,000 | 2,050 | 2,000 | 2,049 | +47 | +2.3% | 225,000 |
2013/12/27 | 1,950 | 2,006 | 1,924 | 2,002 | +45 | +2.3% | 381,000 |
2013/12/26 | 1,910 | 1,963 | 1,895 | 1,957 | +68 | +3.6% | 206,000 |
2013/12/25 | 1,889 | 1,910 | 1,883 | 1,889 | -15 | -0.8% | 249,000 |
2013/12/24 | 1,882 | 1,938 | 1,882 | 1,904 | -38 | -2% | 329,000 |
2013/12/20 | 1,926 | 1,952 | 1,926 | 1,942 | -14 | -0.7% | 258,000 |
2013/12/19 | 1,940 | 1,968 | 1,940 | 1,956 | +12 | +0.6% | 348,000 |
2013/12/18 | 1,948 | 1,948 | 1,924 | 1,944 | +8 | +0.4% | 278,000 |
2751~
2800
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
ペプチド | 168,300円 | +5.0% | +1.5% | 0.00% | 14.40倍 | 3.83倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム